ArticleInternational journal of chronic obstructive pulmonary disease2026
Epigenetic Mechanisms Linking Chronic Obstructive Pulmonary Disease and Atrial Fibrillation: A Multi-Omics Mendelian Randomization Study.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF) frequently co-occur, yet the underlying molecular mechanisms remain unclear. We assessed whether genetic liability to COPD increases AF risk and mapped epigenetic mediators using multi-omics data. Methods: We integrated genome-wide association data for COPD and AF with epigenome-wide DNA methylation profiles and gene expression datasets. Summary-data-based Mendelian randomization served as the primary approach to link disease-associated variants with methylation, gene expression, and AF, complemented by two-sample Mendelian randomization, colocalization, and checks for pleiotropy. We prioritized COPD-related CpG sites and genes, examined functional context using protein-protein interaction networks and pathway enrichment, and nominated candidate therapeutics with drug-prediction algorithms followed by molecular docking. Analyses were conducted primarily in cohorts of European ancestry. Results: Genetic liability to COPD was associated with a higher risk of AF (odds ratio [OR] = 1.156, 95% confidence interval [CI] 1.025-1.304; p = 0.018). We identified 109 COPD-related CpG sites associated with AF risk. Cross-omics triangulation highlighted seven candidate genes, with FES showing consistent evidence across genomic, epigenetic, and transcriptomic layers. Functional analyses indicated enrichment in immune signaling and signal transduction pathways. Docking analyses suggested favorable binding between predicted drugs and their targets. Conclusion: These findings support a pathway by which COPD may influence AF risk through epigenetic regulation and prioritize CpG sites, genes, and potentially druggable targets for further study. Because the underlying datasets are predominantly from individuals of European ancestry, replication in more diverse populations is needed to assess generalizability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.